©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 103198
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.103198
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.103198
Table 5 Correlation analysis
| Parameters | r | P value |
| Hepatitis C (no/yes: 0/1) | 0.207 | 0.008 |
| Tumor diameter (cm) | 0.166 | 0.035 |
| Number of tumors (no/yes: 0/1) | 0.165 | 0.036 |
| Portal vein thrombosis (no/yes: 0/1) | 0.194 | 0.013 |
| Duration of surgery (minutes) | -0.185 | 0.018 |
| AFP (ng/mL) | 0.842 | p < 0.001 |
| AST (U/L) | 0.181 | 0.021 |
| PA (mg/L) | -0.216 | 0.006 |
| FIB (g/L) | 0.201 | 0.010 |
| NLR | 0.191 | 0.015 |
| F-NLR (0/1/2) | 0.266 | p < 0.001 |
- Citation: Liu QQ, Li YD, Chen JX, Zhang LL, Guan RC, Zhao W, Meng LY. Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization. World J Gastrointest Oncol 2025; 17(6): 103198
- URL: https://www.wjgnet.com/1948-5204/full/v17/i6/103198.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.103198